메뉴 건너뛰기




Volumn 63, Issue 22, 2006, Pages 2218-2227

Assessment of adverse drug events among patients in a tertiary care medical center

Author keywords

Age; Errors, medication; Health benefit programs; Hospitals; Quality assurance; Race; Risk management; Sex; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOSPORIN; DOBUTAMINE; DRUG; GENTAMICIN; HEPARIN; INSULIN; LORAZEPAM; PHENOBARBITAL; THEOPHYLLINE; TOBRAMYCIN; VANCOMYCIN; WARFARIN;

EID: 33845195932     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp050405     Document Type: Article
Times cited : (13)

References (37)
  • 1
    • 0030790808 scopus 로고    scopus 로고
    • Preventable adverse drug events in hospitalized patients: A comparative study of intensive care and general care units
    • Cullen DJ, Sweitzer BJ, Bates DW et al. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med. 1997; 25:1289-97.
    • (1997) Crit Care Med , vol.25 , pp. 1289-1297
    • Cullen, D.J.1    Sweitzer, B.J.2    Bates, D.W.3
  • 2
    • 0037048228 scopus 로고    scopus 로고
    • Medication errors observed in 36 health care facilities
    • Barker KN, Flynn EA, Pepper GA et al. Medication errors observed in 36 health care facilities. Arch Intern Med. 2002; 162:1897-903.
    • (2002) Arch Intern Med , vol.162 , pp. 1897-1903
    • Barker, K.N.1    Flynn, E.A.2    Pepper, G.A.3
  • 4
    • 0029066463 scopus 로고
    • Incidence of adverse drug events and potential adverse drug events: Implications for prevention
    • Bates DW, Cullen DJ, Laird N et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995; 274:29-34.
    • (1995) JAMA , vol.274 , pp. 29-34
    • Bates, D.W.1    Cullen, D.J.2    Laird, N.3
  • 5
    • 0019127773 scopus 로고
    • Contribution of patient and hospital characteristics to adverse patient incidents
    • Elnicki RA, Schmitt JP. Contribution of patient and hospital characteristics to adverse patient incidents. Health Serv Res. 1980; 15:397-414.
    • (1980) Health Serv Res , vol.15 , pp. 397-414
    • Elnicki, R.A.1    Schmitt, J.P.2
  • 6
    • 0034106949 scopus 로고    scopus 로고
    • Risk factors for the development of adverse drug events in hospitalized patients
    • Van den Bemt P, Egberts AC, Lenderink AW et al. Risk factors for the development of adverse drug events in hospitalized patients. Pharm World Sci. 2000; 22:62-6.
    • (2000) Pharm World Sci , vol.22 , pp. 62-66
    • Van Den Bemt, P.1    Egberts, A.C.2    Lenderink, A.W.3
  • 8
    • 0036216939 scopus 로고    scopus 로고
    • Frequency and determinants of drug administration errors in the intensive care unit
    • Van den Bemt P, Fijn R, Van der Voort PH et al. Frequency and determinants of drug administration errors in the intensive care unit. Crit Care Med. 2002; 30:846-50.
    • (2002) Crit Care Med , vol.30 , pp. 846-850
    • Van Den Bemt, P.1    Fijn, R.2    Van Der Voort, P.H.3
  • 9
    • 0033187306 scopus 로고    scopus 로고
    • Factors contributing to medication errors: A literature review
    • O'Shea E. Factors contributing to medication errors: a literature review. J Clin Nurs. 1999; 8:496-504.
    • (1999) J Clin Nurs , vol.8 , pp. 496-504
    • O'Shea, E.1
  • 10
    • 77957211615 scopus 로고
    • Prediction of medication error probability based on patient characteristics
    • Raz T, Kraus GP. Prediction of medication error probability based on patient characteristics. Qual Assur Health Care. 1989; 1:207-16.
    • (1989) Qual Assur Health Care , vol.1 , pp. 207-216
    • Raz, T.1    Kraus, G.P.2
  • 11
    • 0033596104 scopus 로고    scopus 로고
    • Patient risk factors for adverse drug events in hospitalized patients
    • Bates DW, Miller EB, Cullen DJ et al. Patient risk factors for adverse drug events in hospitalized patients. Arch Intern Med. 1999; 159:2553-60.
    • (1999) Arch Intern Med , vol.159 , pp. 2553-2560
    • Bates, D.W.1    Miller, E.B.2    Cullen, D.J.3
  • 12
    • 0035879364 scopus 로고    scopus 로고
    • Potential risks and prevention, part 1: Fatal adverse drug events
    • Kelly WN. Potential risks and prevention, part 1: fatal adverse drug events. Am J Health-Syst Pharm. 2001; 58:1317-24.
    • (2001) Am J Health-Syst Pharm , vol.58 , pp. 1317-1324
    • Kelly, W.N.1
  • 13
    • 0035879369 scopus 로고    scopus 로고
    • Potential risks and prevention, part 2: Drug-induced permanent disabilities
    • Kelly WN. Potential risks and prevention, part 2: drug-induced permanent disabilities. Am J Health-Syst Pharm. 2001; 58:1325-9.
    • (2001) Am J Health-Syst Pharm , vol.58 , pp. 1325-1329
    • Kelly, W.N.1
  • 14
    • 0035426247 scopus 로고    scopus 로고
    • Potential risks and prevention, part 3: Drug-induced threats to life
    • Marcellino K, Kelly WN. Potential risks and prevention, part 3: drug-induced threats to life. Am J Health-Syst Pharm. 2001; 58:1399-405.
    • (2001) Am J Health-Syst Pharm , vol.58 , pp. 1399-1405
    • Marcellino, K.1    Kelly, W.N.2
  • 15
    • 0035426249 scopus 로고    scopus 로고
    • Potential risks and prevention, part 4: Reports of significant adverse drug events
    • Kelly WN. Potential risks and prevention, part 4: reports of significant adverse drug events. Am J Health-Syst Pharm. 2001; 58:1406-12.
    • (2001) Am J Health-Syst Pharm , vol.58 , pp. 1406-1412
    • Kelly, W.N.1
  • 16
    • 0035015817 scopus 로고    scopus 로고
    • Can the frequency and risks of fatal adverse drug events be determined?
    • Kelly WN. Can the frequency and risks of fatal adverse drug events be determined? Pharmacotherapy. 2001; 21:521-7.
    • (2001) Pharmacotherapy , vol.21 , pp. 521-527
    • Kelly, W.N.1
  • 17
    • 0037451920 scopus 로고    scopus 로고
    • Adverse drug events in ambulatory care
    • Gandhi TK, Weingart SN, Borus J et al. Adverse drug events in ambulatory care. N Engl J Med. 2003; 348:1556-64.
    • (2003) N Engl J Med , vol.348 , pp. 1556-1564
    • Gandhi, T.K.1    Weingart, S.N.2    Borus, J.3
  • 18
    • 0037224355 scopus 로고    scopus 로고
    • Adverse drug events associated with hospital admission
    • Peyriere H, Cassan S, Floutard E et al. Adverse drug events associated with hospital admission. Ann Pharmacother. 2003; 37:5-11.
    • (2003) Ann Pharmacother , vol.37 , pp. 5-11
    • Peyriere, H.1    Cassan, S.2    Floutard, E.3
  • 19
    • 0027933477 scopus 로고
    • Factors associated with preventable adverse drug reactions
    • Pearson TF, Pittman DG, Longley JM et al. Factors associated with preventable adverse drug reactions. Am J Hosp Pharm. 1994; 51:2268-72.
    • (1994) Am J Hosp Pharm , vol.51 , pp. 2268-2272
    • Pearson, T.F.1    Pittman, D.G.2    Longley, J.M.3
  • 20
    • 3643145805 scopus 로고    scopus 로고
    • Characteristics associated with ability to prevent adverse drug reactions in hospitalized patients
    • Seeger JD, Kong SX, Schumock GT. Characteristics associated with ability to prevent adverse drug reactions in hospitalized patients. Pharmacotherapy. 1998; 18:1284-9.
    • (1998) Pharmacotherapy , vol.18 , pp. 1284-1289
    • Seeger, J.D.1    Kong, S.X.2    Schumock, G.T.3
  • 21
    • 0033014010 scopus 로고    scopus 로고
    • Factors associated with preventability, predictability, and severity of adverse drug reactions
    • Gholami K, Shalviri G. Factors associated with preventability, predictability, and severity of adverse drug reactions. Ann Pharmacother. 1999; 33:236-40.
    • (1999) Ann Pharmacother , vol.33 , pp. 236-240
    • Gholami, K.1    Shalviri, G.2
  • 22
    • 21744432711 scopus 로고    scopus 로고
    • Risk factors for adverse drug events: A 10-year analysis
    • Evans RS, Lloyd JF, Stoddard GJ et al. Risk factors for adverse drug events: a 10-year analysis. Ann Pharmacother. 2005; 39:1161-8.
    • (2005) Ann Pharmacother , vol.39 , pp. 1161-1168
    • Evans, R.S.1    Lloyd, J.F.2    Stoddard, G.J.3
  • 23
    • 0025719244 scopus 로고
    • Computerized surveillance of adverse drug events in hospital patients
    • [Erratum, JAMA. 1992; 267:1922]
    • Classen DC, Pestotnik SL, Evans RS et al. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991; 266:2847-51. [Erratum, JAMA. 1992; 267:1922.]
    • (1991) JAMA , vol.266 , pp. 2847-2851
    • Classen, D.C.1    Pestotnik, S.L.2    Evans, R.S.3
  • 24
    • 0027231164 scopus 로고
    • Incidence and preventability of adverse drug events in hospitalized adults
    • Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med. 1993; 8:289-94.
    • (1993) J Gen Intern Med , vol.8 , pp. 289-294
    • Bates, D.W.1    Leape, L.L.2    Petrycki, S.3
  • 25
    • 0028210219 scopus 로고
    • Preventing adverse drug events in hospitalized patients
    • Evans RS, Pestotnik SE, Classen DC et al. Preventing adverse drug events in hospitalized patients. Ann Pharmacother. 1994; 28:523-7.
    • (1994) Ann Pharmacother , vol.28 , pp. 523-527
    • Evans, R.S.1    Pestotnik, S.E.2    Classen, D.C.3
  • 26
    • 0032556151 scopus 로고    scopus 로고
    • A computer alert system to prevent injury from adverse drug events: Development and evaluation in a community teaching hospital
    • [Erratum, JAMA. 1999; 281:420]
    • Raschke RA, Gollihare B, Wunderlich TA et al. A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital. JAMA. 1998; 280:1317-20. [Erratum, JAMA. 1999; 281:420.]
    • (1998) JAMA , vol.280 , pp. 1317-1320
    • Raschke, R.A.1    Gollihare, B.2    Wunderlich, T.A.3
  • 27
    • 0034302388 scopus 로고    scopus 로고
    • Systematic root cause analysis of adverse drug events in a tertiary referral hospital
    • Rex JH, Turnbull JE, Allen SJ et al. Systematic root cause analysis of adverse drug events in a tertiary referral hospital. Jt Comm J Qual Improv. 2000; 26:563-75.
    • (2000) Jt Comm J Qual Improv , vol.26 , pp. 563-575
    • Rex, J.H.1    Turnbull, J.E.2    Allen, S.J.3
  • 28
    • 0037353241 scopus 로고    scopus 로고
    • Detecting adverse events using information technology
    • Bates DW, Evans RS, Murff H et al. Detecting adverse events using information technology. J Am Med Inform Assoc. 2003; 10:115-28.
    • (2003) J Am Med Inform Assoc , vol.10 , pp. 115-128
    • Bates, D.W.1    Evans, R.S.2    Murff, H.3
  • 29
    • 0037420274 scopus 로고    scopus 로고
    • Incidence of preventability of adverse drug events among older persons in the ambulatory setting
    • Gurwitz JH, Field TS, Harrold ER et al. Incidence of preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003; 289:1107-16.
    • (2003) JAMA , vol.289 , pp. 1107-1116
    • Gurwitz, J.H.1    Field, T.S.2    Harrold, E.R.3
  • 30
    • 0034253924 scopus 로고    scopus 로고
    • Incidence and preventability of adverse drug events in nursing homes
    • Gurwitz JH, Field TS, Avorn J et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med. 2000; 109:87-94.
    • (2000) Am J Med , vol.109 , pp. 87-94
    • Gurwitz, J.H.1    Field, T.S.2    Avorn, J.3
  • 31
    • 0037383538 scopus 로고    scopus 로고
    • Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients
    • Fortescue EB, Kaushal R, Landrigan CP et al. Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients. Pediatrics. 2003; 111:722-9.
    • (2003) Pediatrics , vol.111 , pp. 722-729
    • Fortescue, E.B.1    Kaushal, R.2    Landrigan, C.P.3
  • 32
    • 0031032055 scopus 로고    scopus 로고
    • Adverse drug events in hospitalized patients: Excess length of stay, extra costs and attributable mortality
    • Classen DC, Pestotnik SL, Evans RS et al. Adverse drug events in hospitalized patients: excess length of stay, extra costs and attributable mortality. JAMA. 1997; 277:301-6.
    • (1997) JAMA , vol.277 , pp. 301-306
    • Classen, D.C.1    Pestotnik, S.L.2    Evans, R.S.3
  • 33
    • 0031012726 scopus 로고    scopus 로고
    • The costs of adverse drug events in hospitalized patients
    • Bates DW, Spell N, Cullen DJ et al. The costs of adverse drug events in hospitalized patients. JAMA. 1997; 277:307-11.
    • (1997) JAMA , vol.277 , pp. 307-311
    • Bates, D.W.1    Spell, N.2    Cullen, D.J.3
  • 34
  • 35
    • 0037106164 scopus 로고    scopus 로고
    • Identifying clinically significant preventable adverse drug events through a hospital's database of adverse drug reaction reports
    • Winterstein AG, Hatton RC, Gonzalez-Rothi R et al. Identifying clinically significant preventable adverse drug events through a hospital's database of adverse drug reaction reports. Am J Health-Syst Pharm. 2002; 59:1742-9.
    • (2002) Am J Health-Syst Pharm , vol.59 , pp. 1742-1749
    • Winterstein, A.G.1    Hatton, R.C.2    Gonzalez-Rothi, R.3
  • 36
    • 8344254303 scopus 로고    scopus 로고
    • Nature and causes of clinically significant medication errors in a tertiary care hospital
    • Winterstein AG, Johns TE, Rosenberg EI et al. Nature and causes of clinically significant medication errors in a tertiary care hospital. Am J Health-Syst Pharm. 2004; 61:1908-16.
    • (2004) Am J Health-Syst Pharm , vol.61 , pp. 1908-1916
    • Winterstein, A.G.1    Johns, T.E.2    Rosenberg, E.I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.